NCT03260842
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
At risk: Primary completion moved 2 years later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 6 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Apr 30, 2028 to Apr 30, 2030
- Eligibility criteria expanded, about 4 words
- Study completion pushed from Apr 30, 2030 to Apr 30, 2032
- Study description expanded, about 2 words
- Minor Study description shortened, about 14 words
- Collaborators shortened, about 4 words
- Notable Primary completion date: Apr 30, 2023 to Apr 30, 2028
- Study completion date: Apr 30, 2023 to Apr 30, 2030
- Notable Primary and study completion dates: Apr 30, 2022 to Apr 30, 2023v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Pancreas Cancer
Timeframe: 5-10 years
Arms and interventions
Pancreatic Cysts
Patients with pancreatic cyst undergoing endoscopic ultrasound and/or surgery who will have bio-specimens collected
High Risk Individuals
Patients with established family history and/or genetic mutations for Pancreas cancer who will have bio-specimens collected
Diagnostic tests: Bio-Specimen Collection
Sites
1 site in 1 country
- Stanford UniversityStanford, California, United States